What is UroGen Pharma's software and technology licenses, net?

UroGen Pharma (URGN) reported software and technology licenses, net of $7.49M in Q1 2026.

How has UroGen Pharma's software and technology licenses, net changed year-over-year?

UroGen Pharma's software and technology licenses, net increased by 1919.7% year-over-year, from $371K to $7.49M.

What is the long-term trend for UroGen Pharma's software and technology licenses, net?

Over 5 years (2020 to 2025), UroGen Pharma's software and technology licenses, net has grown at a 139.1% compound annual growth rate (CAGR), from $66K to $5.16M.

UroGen Pharma URGN Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Bristol-Myers SquibbBMY

——

PfizerPFE

——

Johnson & JohnsonJNJ

——

Merck & Co.MRK

——

Tyra Biosciences, Inc.TYRA

——

CG OncologyCGON

——

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.73B+71.7%

Enterprise value$1.81B+80.9%

P/S12.3×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Debt / equity4.8×—

Current ratio4.7×-1.0×

Where this comes from

Reported directly by UroGen Pharma in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's software and technology licenses, net?: UroGen Pharma (URGN) reported software and technology licenses, net of $7.49M in Q1 2026.
How has UroGen Pharma's software and technology licenses, net changed year-over-year?: UroGen Pharma's software and technology licenses, net increased by 1919.7% year-over-year, from $371K to $7.49M.
What is the long-term trend for UroGen Pharma's software and technology licenses, net?: Over 5 years (2020 to 2025), UroGen Pharma's software and technology licenses, net has grown at a 139.1% compound annual growth rate (CAGR), from $66K to $5.16M.